Background 

Researchers are learning that the human microbiome, which is the community of bacteria living in and on our bodies, plays an important role in health and disease. Some bacteria can actually cause problems, like increasing the risk of cancer by creating inflammation. But other bacteria may help the body fight cancer by activating the immune system to recognize and attack tumors. One of these helpful bacteria may be Lactobacillus.  

What This Research Proposes to Address 

The researchers plan to test whether adding Lactobacillus directly into the bladder can help treat bladder cancer. They performed this in mice that had bladder tumors. Some mice will receive Lactobacillus alone, while others will receive it along with BCG, the standard treatment for early-stage bladder cancer. The team carefully measured how the tumors respond and studied how the immune system reacts during treatment. 

Why This Research Is Important 

If successful, this research could lead to a new treatment option that is safe, non-toxic, and widely available. Lactobacillus could be used either as an alternative to current therapies or together with standard treatments like BCG. This could provide a gentler, potentially more effective way to help the body fight early-stage bladder cancer, giving patients additional choices in their care. 

In the long term, this study could open the door to treatments that use the body’s own immune system, supported by helpful bacteria, to fight bladder cancer more effectively. 

Final Report Summary

This study looked at how the immune system reacts to different bladder cancer treatments by measuring special signals in the body called cytokines. Cytokines help the body fight infections and cancer, so understanding how they change after treatment is important. 

The results showed that each treatment—LGG, chemotherapy, and BCG—caused different immune responses. The LGG treatment created the strongest signal, which may mean it helps the immune system fight cancer more effectively. In comparison, people who had no treatment showed very weak signals, showing how important treatment is in waking up the body’s defenses. 

One interesting finding was that BCG treatment caused a strong rise in a specific cytokine called RANTES. This could become a marker to tell doctors how well BCG works, and it might help explain why BCG is effective for some patients. 

These results suggest that studying cytokine changes could help researchers improve current bladder cancer treatments or even create new ones. While these are early findings that still need more research, they give us valuable clues about how the immune system can be used to fight cancer more effectively. 

None Reported as of August 2025

None Reported as of August 2025

NA